Journal of the American Academy of Dermatology
Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature.
Journal of the American Academy of Dermatology
The use of trimethoprim-sulfamethoxazole for acne should be restricted to patients who are unable to tolerate tetracyclines or in treatment-resistant patients.
2016
https://www.jaad.org/article/S0190-9622(15)02614-6/fulltext#tbl6
`
Cutis
Oral trimethoprim-sulfamethoxazole in the treatment of acne vulgaris.
Cutis
A review of the use of trimethoprim-sulfamethoxazole in the treatment of acne concluded it should be used judiciously and reserved for those who have failed other antibiotic therapies.
2007
https://mdedge-files-live.s3.us-east-2.amazonaws.com/files/s3fs-public/Document/September-2017/079060430.pdf
`
Journal of Drugs in Dermatology
Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris
Journal of Drugs in Dermatology
A review of the use of systemic antibiotics for acne describes trimethoprim-sulfamethoxazole as a relatively safe and successful third-line agent in refractory cases of acne.
2007
https://www.researchgate.net/profile/Eric_Schweiger/publication/5904939_Common_and_alternate_oral_antibiotic_therapies_for_acne_vulgaris_a_review/links/0fcfd50b4bec1aec10000000/Common-and-alternate-oral-antibiotic-therapies-for-acne-vulgaris-a-review.pdf
`
Cutis
A comparison of low dosage trimethoprim/sulfamethoxazole with oxytetracycline in acne vulgaris.
Cutis
A double-blind study demonstrated that trimethoprim/sulfamethoxazole is an equally safe and effective therapeutic agent as oxytetracycline.
1980
https://europepmc.org/article/med/6446446
`
Dermatologica
Trimethoprim-sulfamethoxazole in acne vulgaris: a double-blind study.
Dermatologica
A double-blind, crossover trial involving 43 patients demonstrated that trimethoprim-sulfamethoxazole 80/400mg given once daily produced a statistically significant improvement in acne over placebo.
1972
https://www.karger.com/Article/Abstract/252042
`